← Compounds

Adamax

peptide · headlineResearch use only

Upregulates BDNF (brain-derived neurotrophic factor) expression in hippocampus and cortex

Summary

Adamax is a next-generation nootropic peptide and enhanced Semax analog featuring N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration. It upregulates BDNF, enhances TrkB receptor sensitivity, modulates monoamines, and provides neuroprotection against oxidative stress and excitotoxicity.

How it works

  • Upregulates BDNF (brain-derived neurotrophic factor) expression in hippocampus and cortex
  • Enhances TrkB receptor sensitivity for improved neurotrophin signaling
  • Modulates monoamine neurotransmitter levels (dopamine, norepinephrine, serotonin)
  • Activates neuroprotective pathways reducing oxidative stress
  • Stabilizes microtubules through ADNP-derived mechanisms
  • Reduces excitotoxicity through neuromodulation

Dosing

  • unit: mcg
    low dose: 300
    frequency: daily
    high dose: 1000
    standard dose: 500
    administration route: Intranasal Spray
  • unit: mcg
    low dose: 100
    frequency: daily
    high dose: 500
    standard dose: 300
    administration route: Subcutaneous Injection

Cycling

  • Can be used daily without cycling; however, some users rotate 5 days on / 2 days off to prevent tolerance development. Nasal mucosa health should be monitored during extended use.
  • Daily administration recommended without cycling for cognitive support. Some protocols suggest 3 weeks on / 1 week off for tolerance management.

Side effects

common: ["Nasal irritation or congestion (intranasal administration)","Mild headache (usually transient)","Slight insomnia if dosed late in the day"]
warnings: ["May cause anxiety or overstimulation at high doses","Risk of sleep disruption if taken in evening","Limited long-term human safety data available"]
long term: ["Long-term safety profile unknown in humans","Extrapolated from Semax clinical experience only"]

Chemistry & PK

sequence: Ac-SEMAX-Adamantyl
half life: 2-4 hours (intranasal); 6-8 hours (subcutaneous)
degradation: Enzymatic degradation by serum proteases; slower degradation than native Semax due to adamantane modification.
molecular weight: 1568
molecular formula: C72H111N21O13
tissue specificity: CNS-specific distribution with high hippocampal, cortical, and striatal accumulation.

Used for

No condition evidence rows yet.

Legal / compounding

Research use only

Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.